SIGLEC15 and osteosarcoma: Jude PeCan database, among common pediatric cancers, we found higher SIGLEC15 expression in B-ALL, AML, mixed lineage leukemia, and osteosarcoma relative to the median expression across all tumors (Fig. 1B).